Exclusive Research

News Articles for Exclusive Research top ^
Charles & Colvard, Ltd.
Sign-up for Charles & Colvard and Cree Enter Into a New Exclusive Supply Agreement investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979413001&sourceType=1 http://www.ccnmatthews.com/logos/20090614-orslo.JPG LONDON, UNITED KINGDOM --
Sign-up for Orsu Metals Corporation: New Exclusivity Agreement for Potential Sale of Akdjol-Tokhtazan Project investment picks
AVEO Oncology (NASDAQ:AVEO) today announced that it has entered into a research and exclusive option agreement with Ophthotech Corporation, under which it has provided Ophthotech an exclusive license to investigate the potential of AVEO’s small molecule vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor, tivozanib, outside of Asia for the potential treatment of non-oncologic diseases of the eye.
Sign-up for AVEO Enters into Research and Exclusive Option Agreement with Ophthotech for Tivozanib (VEGF inhibitor) for the Treatment of Ocular Diseases investment picks
Bristol-Myers Squibb Company (NYSE:BMY) and Galecto Biotech AB today announced that the companies, together with the Galecto shareholders, have entered into an agreement that provides Bristol-Myers Squibb the exclusive option to acquire Galecto Biotech AB and gain worldwide rights to its lead asset TD139, a novel inhaled inhibitor of galectin-3 in Phase 1 development for the treatment of idiopathic pulmonary fibrosis (IPF) and other pulmonary fibrotic conditions.
Sign-up for Bristol-Myers Squibb Signs Exclusive Option Agreement to Acquire Galecto Biotech AB and Its Novel Galectin-3 Inhibitor in Development for Idiopathic Pulmonary Fibrosis investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026910-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/20/11G026910/af9d7838a4da9e6e_org-394299677.jpg NEW YORK, NY--(Marketwired - November 20, 2014) - Taboola, the leading discovery platform, today announced an exclusive strategic partnership with Tribune Broadcasting, a subsidiary of the Tribune Media Company.
Sign-up for Tribune Broadcasting Working Exclusively With Taboola, Personalized Content Recommendations Now Appear Across 40 Websites And 80 Mobile Apps investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0984003001&sourceType=1 http://media3.marketwire.com/logos/20131105-Sonde.jpg CALGARY, ALBERTA --
Sign-up for Sonde Resources Corp. Executes Exclusivity Agreement and Pays Exploratory Well Penalty investment picks
2K and Turtle Rock Studios announced today that the Open Beta test for the much anticipated 4v1 shooter, Evolve™ , is coming exclusively to Xbox One, the all-in-one games and entertainment system from Microsoft, January 15 – 19, 2015.
Sign-up for Evolve™ Open Beta Exclusively on Xbox One January 15 – 19, 2015 investment picks
Tiny Prints, the leading online stationery boutique, today unveils its exclusive holiday charity card collection , a percentage of which will benefit Baby2Baby , a non-profit organization that provides low-income children, ages zero to 12, with diapers, clothing and all the basic necessities that every child deserves.
Sign-up for Tiny Prints Gives Back This Holiday Season with an Exclusive Holiday Card Collection Benefiting Non-Profit Baby2Baby investment picks
Hilton Worldwide today announced an exclusive license agreement with Plateno Hotels Group, one of China’s leading hospitality groups, to rapidly launch and develop the Hampton by Hilton brand in China.
Sign-up for Hilton Worldwide Signs Exclusive License Agreement for Major Expansion of Hampton by Hilton Hotels in China investment picks
The Tile Shop (NASDAQ:TTS), a specialty retailer of manufactured and natural stone tiles and installation materials, today announced the introduction of a 2015 Design Preview , a catalog format available online and in The Tile Shop stores around the country that showcases exclusive tile and natural stone collections, a complete style profile guide, design tips and product installation recommendations.
Sign-up for The Tile Shop Introduces 2015 Design Preview, Providing Inspiration and Exclusive Collections to Consumers and Trade Professionals investment picks
3PEA International, Inc. ( OTCBB:TPNL ) ( OTCQB:TPNL ), a vertically integrated provider of innovative prepaid card programs and processing services for corporate, consumer and government applications, is pleased to announce that B Positive National Blood Services has selected 3PEA International to provide its comprehensive PaySign® prepaid solution as its exclusive plasma donor payment solution.
Sign-up for B Positive National Blood Services Selects 3PEA International’s PaySign as its Exclusive Donor Payment Solution investment picks
Bristol-Myers Squibb Company (NYSE:BMY) and F-star Alpha Ltd.
Sign-up for Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy investment picks
Internationally acclaimed artist to answer questions in front of SiriusXM listeners and fans Juan Luis Guerra to premiere track off his new album "Todo Tiene Su Hora" In-studio Q&A special will air on SiriusXM Caliente NEW YORK , Nov.
Sign-up for SiriusXM to Broadcast Exclusive Town Hall Event with Juan Luis Guerra investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G026579-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/17/11G026579/EPIC_Corporation-949224062297.jpg AUSTIN, TX--(Marketwired - November 17, 2014) - EPIC Corporation Inc. (PINKSHEETS: EPOR) announces EPIC has acquired an exclusive worldwide license to all the rights to the EPIC Fabric Healthcare Products in exchange for all its ownership rights to the AcuFAB® trade name and design patent which was valued at $1.95 Million and receives a $1 Million License Fee from EPIC Medicor Corporation for Marketing & Distribution rights of EPIC Fabric Healthcare Products.
Sign-up for EPIC Acquires Exclusive Worldwide License to Healthcare Products Valued at $1.95M investment picks
MakerBot , a world leader in the desktop 3D printing industry, and Martha Stewart Living Omnimedia Inc. (MSLO), today announced an exclusive agreement to distribute 3D printing materials and jointly develop 3D printable designs .
Sign-up for MakerBot to Launch Exclusive Partnership with Martha Stewart Living Omnimedia investment picks
Nickelodeon and Playmates Toys, the companies behind the hit TV show and number-one-selling action-figure brand, Teenage Mutant Ninjas Turtles , today announced the launch of its Bebop and Rocksteady action figures available mid-November exclusively at Walmart.
Sign-up for Teenage Mutant Ninja Turtles’ Dynamic Duo Bebop and Rocksteady Launch Exclusively at Walmart investment picks
Bristol-Myers Squibb Company (NYSE:BMY) and Five Prime Therapeutics, Inc. (Nasdaq:FPRX) today announced that they have entered into an exclusive clinical collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of combining Opdivo (nivolumab), Bristol-Myers Squibb’s investigational PD-1 (programmed death-1) immune checkpoint inhibitor, with FPA008, Five Prime’s monoclonal antibody that inhibits colony stimulating factor-1 receptor (CSF1R). The Phase 1a/1b study will evaluate the combination of Opdivo and FPA008 as a potential treatment option for patients with non-small cell lung cancer (NSCLC), melanoma, head and neck cancer, pancreatic cancer, colorectal cancer and malignant glioma.
Sign-up for Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types investment picks
Time Inc. (NYSE:TIME), one of the world’s leading media companies, is the exclusive magazine launch partner for JetBlue’s Fly-Fi Hub, which went live this morning.
Sign-up for Time Inc. Is Exclusive Magazine Launch Partner for JetBlue’s Fly-Fi Hub investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar

Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Exclusive Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Exclusive Option  |  Next: Executive Management